Cargando…

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis

Detalles Bibliográficos
Autores principales:	Zheng, Shirong, Powell, David W., Zheng, Feng, Kantharidis, Phillip, Gnudi, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736592/ https://www.ncbi.nlm.nih.gov/pubmed/26881250 http://dx.doi.org/10.1155/2016/5241549

Ejemplares similares

Angiopoietins and diabetic nephropathy
por: Gnudi, Luigi
Publicado: (2016)

The role of sirolimus in proteinuria in diabetic nephropathy rats
por: Wang, JinJun, et al.
Publicado: (2017)

Endothelial Factors and Diabetic Nephropathy
por: Karalliedde, Janaka, et al.
Publicado: (2011)

MicroRNA in Diabetic Nephropathy: Renin Angiotensin, AGE/RAGE, and Oxidative Stress Pathway
por: Hagiwara, Shinji, et al.
Publicado: (2013)

Immune Cells and Inflammation in Diabetic Nephropathy
por: Zheng, Zihan, et al.
Publicado: (2016)

An integrin antagonist (MK‐0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model
por: Zhou, Xiaoyan, et al.
Publicado: (2017)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy
por: Kim, Sang Soo, et al.
Publicado: (2013)

Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs
por: Sakuma, Hiroko, et al.
Publicado: (2020)

Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression
por: Xue, Lingyu, et al.
Publicado: (2017)

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase
por: Sharma, Arpeeta, et al.
Publicado: (2023)

Diabetic nephropathy: What does the future hold?
por: Montero, R. M., et al.
Publicado: (2015)

Establishment and Validation of a Nomogram Model for Prediction of Diabetic Nephropathy in Type 2 Diabetic Patients with Proteinuria
por: Zhou, Dong-mei, et al.
Publicado: (2022)

Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab
por: Hanna, Ramy M, et al.
Publicado: (2020)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2013)

Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
por: Iwasaki, Chihiro, et al.
Publicado: (2016)

P01-030 – Proteinuria in FMF – prediction of nephropathy type
por: Kukuy, OL, et al.
Publicado: (2013)

Addition of nonalbumin proteinuria to albuminuria improves prediction of type 2 diabetic nephropathy progression
por: Kim, Jong Ho, et al.
Publicado: (2017)

Identification of Key Genes of Human Advanced Diabetic Nephropathy Independent of Proteinuria by Transcriptome Analysis
por: Cai, Fanghao, et al.
Publicado: (2020)

Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
por: Aref, Asieh, et al.
Publicado: (2022)

Clinical Efficacy of Dapagliflozin in the Treatment of Patients with Diabetic Nephropathy and Its Effect on Proteinuria Level
por: Jin, Ze-Jun, et al.
Publicado: (2023)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

CBGA ameliorates inflammation and fibrosis in nephropathy
por: Suzuki, Sayuri, et al.
Publicado: (2023)

Proteinuria in Diabetes
por: Thomas, Stephen, et al.
Publicado: (2000)

Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial
por: Jo, Young-Il, et al.
Publicado: (2016)

Iron Chelator Deferoxamine Alleviates Progression of Diabetic Nephropathy by Relieving Inflammation and Fibrosis in Rats
por: Feng, Yunfei, et al.
Publicado: (2023)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018)

Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2019)

Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria
por: He, Peng, et al.
Publicado: (2021)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

FGF23(C-tail) improves diabetic nephropathy by attenuating renal fibrosis and inflammation
por: Zhang, Xiaomin, et al.
Publicado: (2018)

Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy
por: Czajka, Anna, et al.
Publicado: (2015)

Diabetic Nephropathy: From Pathophysiology to Treatment
por: Shen, Ziyan, et al.
Publicado: (2017)

Weight loss for reduction of proteinuria in diabetic nephropathy: Comparison with angiotensin-converting enzyme inhibitor therapy
por: Patil, M. R., et al.
Publicado: (2013)

Curcumin as a major active component of turmeric attenuates proteinuria in patients with overt diabetic nephropathy
por: Vanaie, Azam, et al.
Publicado: (2019)

Demethylzeylasteral reduces the level of proteinuria in diabetic nephropathy: Screening of network pharmacology and verification by animal experiment
por: Xu, Lengnan, et al.
Publicado: (2022)

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
por: Fukami, Kei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nu2dudk10bbaunhg0vh6bfnies